IFF Publishes CAGNY Investor Presentation on Strategic Progress and Business Growth Priorities

Reuters02-20 03:04
IFF Publishes CAGNY Investor Presentation on Strategic Progress and Business Growth Priorities

IFF – International Flavors & Fragrances Inc. shared an investor presentation at the 2026 CAGNY Conference outlining its business profile and segment overview across Taste, Health & Biosciences and Scent. The company highlighted FY 2025 scale metrics including $10.9 billion in sales, a 19.2% EBITDA margin, approximately 20,000 customers and about 21,500 employees, along with a sales mix spanning Health & Biosciences (22%), Scent (24%), Food Ingredients (31%) and Taste (24%). IFF also discussed portfolio actions, including 11 divestitures generating more than $6 billion in gross proceeds, and noted net debt to credit-adjusted EBITDA of 2.6x in 2025. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IFF - International Flavors & Fragrances Inc. published the original content used to generate this news brief on February 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment